Cinnageron en es it fr

Cinnageron Brand names, Cinnageron Analogs

Cinnageron Brand Names Mixture

  • No information avaliable

Cinnageron Chemical_Formula

C26H28N2

Cinnageron RX_link

No information avaliable

Cinnageron fda sheet

Cinnageron msds (material safety sheet)

Cinnageron Synthesis Reference

No information avaliable

Cinnageron Molecular Weight

368.514 g/mol

Cinnageron Melting Point

No information avaliable

Cinnageron H2O Solubility

750 mg/L

Cinnageron State

Solid

Cinnageron LogP

5.63

Cinnageron Dosage Forms

No information avaliable

Cinnageron Indication

For the treatment of vertigo/meniere's disease, nausea and vomiting, motion sickness and also useful for vestibular symptoms of other origins.

Cinnageron Pharmacology

Cinnarizine is an antihistamine and a calcium channel blocker. Histamines mediate a number of activities such as contraction of smooth muscle of the airways and gastrointestinal tract, vasodilatation, cardiac stimulation, secretion of gastric acid, promotion of interleukin release and chemotaxis of eosinophils and mast cells. Competitive antagonists at histamine H1 receptors may be divided into first (sedating) and second (non-sedating) generation agents. Some, such as Cinnarizine also block muscarinic acetylcholine receptors and are used as anti-emetic agents. Cinnarizine through its calcium channel blocking ability also inhibits stimulation of the vestibular system.

Cinnageron Absorption

No information avaliable

Cinnageron side effects and Toxicity

No information avaliable

Cinnageron Patient Information

No information avaliable

Cinnageron Organisms Affected

Humans and other mammals